Pulmonary diseases due to mycobacteria cause significant morbidity and mortality to human
health. In addition to tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), recent …

The development, evaluation, and implementation of new and improved diagnostics have
been identified as critical needs by human immunodeficiency virus (HIV) and tuberculosis …

The reports of nontuberculous mycobacteria (NTM) associated with extrapulmonary
diseases are increasing in tertiary care hospitals. Despite a significant increase in …

Background: Mycobacterium tuberculosis complex (MTBC) and non-tuberculous
mycobacteria (NTM) may or may not have same clinical presentations, but the treatment …

The World Health Organization (WHO) estimates that 40% of tuberculosis (TB) cases are not
diagnosed and treated correctly. Even though there are several diagnostic tests available in …

The prevalence of Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD) is
increasing worldwide. The advancement in molecular diagnostic technology has greatly …

TB persists as a global epidemic with high morbidity and mortality, especially in low-income
countries. It is the only infectious disease ever declared as a global emergency by the WHO …

Background Multiple techniques exist for detecting Mycobacteria, each having its own
advantages and drawbacks. Among them, automated culture-based systems like the …

Avian tuberculosis is a chronic, contagious zoonotic disease affecting birds, mammals, and
humans. The disease is most often caused by Mycobacterium avium spp. avium (MAA) …

There is an urgent need for simple, rapid, and affordable diagnostic tests for tuberculosis
(TB) to combat the great burden of the disease in developing countries. The microscopic …